THE BASIC PRINCIPLES OF CENZO PHARMA

If not able to keep away from coadministration of belzutifan with sensitive CYP3A4 substrates, consider rising the sensitive CYP3A4 substrate dose in accordance with its prescribing information and facts. dexamethasone will reduce the level or outcome of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use warning/Monitor. as